Global Enteric Disease Testing Market By Disease Type (Bacterial Enteric Disease, Viral Enteric Disease and Parasitic Enteric Disease), By Application (Hospitals, Research Centers, And Clinics) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Enteric Disease Testing Market Overview:

The global enteric disease testing market was valued at USD 3,827.3 million in 2021 and is forecast to grow at a CAGR of 2.7% in the estimated period.

This market is driven by technological advances and government support in developing countries. The market’s growth will be fueled by a growing demand for early diagnostics in the global marketplace.

Global Enteric Disease Testing Market Scope:

Disease Type Analysis

The key segments are divided by disease type. These bacteria can cause various diseases, including C. difficile, E. coli Shigella Salmonella, and Campylobacter. These bacteria accounted for 66.21% of the market’s revenue share in 2021, while the viral enteric disease testing market accounted for a substantial portion. Parasitic disease testing will see significant growth over the next seven years due to the rising incidence of these infections and the emergence of new parasitic strains.

Child Health Epidemiology Research Group, (CHERG) has found that enteric pathogens like Rotavirus, Salmonella spp., and V. cholera cause more deaths than any other enteric disease. Therefore, the WHO committee has made it a priority to develop new and better vaccines for these pathogens.

Although some viruses can be found everywhere, like rotavirus which affects approximately 90 percent of the world’s children under five years old, infections are often caused by environmental factors. These include restricted geographical and seasonal patterns, as well as hygiene and access to clean water.

Маrkеt Ѕеgmеntѕ

Disease Type

• Bacterial Enteric Disease
• Viral Enteric Disease
• Parasitic Enteric Disease

End-Use

• Hospitals
• Research Centers
• Clinics

Market Dynamics:

The cultural method was the traditional way to diagnose enteric diseases. This required skilled personnel and was time-consuming. This market for disease testing has seen a significant shift in the past decade with the advent of molecular diagnostics. These conditions are increasing mortality and the high cost of technically advanced diagnostic systems will drive demand for initial diagnosis.

Enteric disease symptoms can manifest as anorexia, nausea, vomiting, and abdominal cramps. This could lead to serious conditions like severe fluid loss and the elimination of essential nutrients. These conditions are more common in children and the elderly.

Sometimes, the mild symptoms at first are ignored and can be a problem for the enteric disease testing market. Globally, enteric illnesses are a leading cause of mortality and morbidity. They are more common in countries with poor drainage and hygiene. In terms of epidemiology and incidence, it is believed that more than 80% are caused by these diseases in developing countries.

The rising cases of enteric disorders and the efficiency of modern diagnostic systems will drive the demand for early diagnosis. A traditional diagnostic method was tedious and time-consuming. The enteric disease testing market has seen a revolution in the past decade with the development of molecular diagnostics. The market for enteric disease testing is estimated to grow over the forecast period due to increasing demand for early diagnosis.

Many areas of microbiology use molecular diagnostics, including strain identification and isolation. Different molecular diagnostics methods can be used to study disease-causing microorganisms. Molecular diagnostics will become more common in microbiology due to technologically advanced instruments that provide higher accuracy. As part of laboratory automation, clinical laboratories are adopting molecular diagnosis. The market for the enteric disease is expected to grow over the forecast period due to the increasing adoption of molecular diagnostics for the detection of enteric disorders.

The market’s growth will be slowed by the insufficient awareness of patients in developing countries, and the rising incidence of undiagnosed enteric disease. Market growth may also be impeded by the absence of reimbursement policies for developing countries like India and China. The high cost of diagnostic equipment limits new entrants.

Regional Analysis

Asia Pacific region was the dominant market by revenue, with more than 30% of the global market share in 2021. It is expected to continue growing at a CAGR in excess of 5 % during the estimated period.

The most attractive regions are located in developing countries like India and China. This promotes Asia Pacific’s fastest growth. Due to increasing awareness and increased infections, Asia Pacific will be able to capture a 35% global revenue share by 2032.

Germany has a significant share of Europe’s market for enteric disease testing, mainly due to its elderly population. The increased geriatric population poses problems due to the increased risk of enteric disease and decreased immunity. This demographic is well-served by point-of-care diagnostic devices and rapid diagnostic techniques.
Brazil holds strong market growth opportunities. Brazil has experienced positive economic growth due to political stability and economic growth. The Unified Health System (SUS) is a system that provides free healthcare to all citizens of all ages. The SUS provides a mix of private and public healthcare services.

Kеу Regions and Countries covered in the rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Key Companies & Market share:

Corporations such as Bio-Rad Laboratories, Alere Inc., Quest Diagnostics, Cepheid, Meridian Biosciences, Coris BoConcept, Becton Dickinson, and Company. To maintain their market position and provide cost-effective solutions, the players engage in technological advancement and product development.

Маrkеt Рlауеrѕ іnсludеd in the rероrt:

• Quest Diagnostics
• Bio-Rad Laboratories
• Merit Medical System
• Alere Inc
• Cepheid
• Becton Dickinson and Company
• DiaSorin
• Meridian Bioscience Inc.
• Other Key Players

For the Enteric Disease Testing Market research study, the following years have been considered to estimate the market size: